Product Program year 2020 Source: CMS Open Payments

Bevyxxa

Biological Cardiology/Hematology

NDC 69853-0202-1

Open in the dashboard

General payments

$17,054

79 payments

Research payments

$47,411

1 payment

Through program year 2020, $17,054 in general payments and $47,411 in research payments were reported against Bevyxxa (Cardiology/Hematology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 Research $47,411 1
2019 General $17,054 79

Breakdown

Who paid General payments · program year 2019
  1. Portola Pharmaceuticals, Inc. $17,054 79 payments
Top recipients General payments · program year 2019
  1. Hoang Le Pulmonary Disease · Fountain Valley, CA $4,246 25% · 4 payments
  2. Michael Oleksyk Internal Medicine · Fort Myers, FL $2,466 14% · 6 payments
  3. Hameed Ali Internal Medicine · Temple, TX $2,221 13% · 4 payments
  4. David Zisman Pulmonary Disease · Weston, FL $2,104 12% · 2 payments
  5. Paryus Patel Pulmonary Disease · Inglewood, CA $2,093 12% · 3 payments

The top 5 of 64 recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Pulmonary Disease Internal Medicine $8,506 50% · 4 practitioners
  2. Internal Medicine $5,661 33% · 11 practitioners
  3. Family Medicine $543 3% · 8 practitioners
  4. Anesthesiology $299 2% · 4 practitioners
  5. Neurology Psychiatry & Neurology $239 1% · 5 practitioners

The top 5 of 26 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. California $10,409 61% · 34 recipients
  2. Texas $2,767 16% · 6 recipients
  3. North Carolina $2,466 14% · 1 recipient
  4. Florida $561 3% · 12 recipients
  5. Virginia $150 <1% · 2 recipients

The top 5 of 14 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

79 general · 1 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record